Our mission and strategy
Our mission is to help people do more, feel better, live longer.
The business is focused around the delivery of our strategic priorities which aim to increase growth, reduce risk and improve our long-term financial performance. These priorities are: grow a balanced global business, deliver more products of value, simplify the operating model and be a responsible business.
Operating responsibly and ensuring our values are embedded in our culture and decision-making helps us better meet the expectations of society.
Grow a balanced business
We have been creating a more balanced business and product portfolio, capable of delivering sustainable sales and earnings growth and improved returns to shareholders.
This is centred on our three business areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
Group turnover outside USA and Europe
Deliver more products of value
We have changed our R&D organisation so that it is better able to sustain a pipeline of products that offer valuable improvements in treatment for patients and healthcare providers.
This is underpinned by a focus on improving productivity and rates of return in R&D.
assets with data expected by 2018
candidate vaccines in early, mid and late stage development
Our range of partners includes academic institutions, public-private partnerships, pharmaceutical and biotechnology companies
Simplify the operating model
As our business continues to change shape, we are transforming how we operate so that we can reduce complexity and become more efficient.
This frees up resources to reinvest elsewhere in the business, or return to shareholders wherever we see the most attractive returns.
Being a responsible business is central to our strategy, and how we deliver success is just as important as what we achieve. Ensuring our values are embedded in our culture and decision-making helps us better meet the expectations of society.
markets operating our new commercial model
in the Access to Medicine Index since launch in 2008
in the Pharmaceutical sector Dow Jones Sustainability Index score for economic, environmental and social performance
Find out more about us
What we do
We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare
Explore GSK, the people behind it and a range of opportunities to be part of an organisation that helps people around the world to do more, feel better, live longer
Science can improve health and well-being in so many ways, from the development of everyday convenience healthcare products through to life-saving medicines and vaccines
Responsible business is how we do business. Our mission is to improve the quality of human life by enabling people to do more, feel better, live longer